Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Short-Term Debt issuances (2016 - 2020)

Haemonetics has reported Short-Term Debt issuances over the past 12 years, most recently at -$150.0 million for Q4 2020.

  • For Q4 2020, Short-Term Debt issuances fell 3100.0% year-over-year to -$150.0 million; the TTM value through Oct 2021 reached -$150.0 million, down 236.36%, while the annual FY2021 figure was -$60.0 million, 233.33% down from the prior year.
  • Short-Term Debt issuances for Q4 2020 was -$150.0 million at Haemonetics, down from -$60.0 million in the prior quarter.
  • Over five years, Short-Term Debt issuances peaked at $150.0 million in Q2 2020 and troughed at -$150.0 million in Q4 2020.
  • A 5-year average of -$3.2 million and a median of $145000.0 in 2016 define the central range for Short-Term Debt issuances.
  • Biggest five-year swings in Short-Term Debt issuances: plummeted 18300.46% in 2016 and later skyrocketed 16204.35% in 2019.
  • Year by year, Short-Term Debt issuances stood at -$39.9 million in 2016, then soared by 100.41% to $162000.0 in 2017, then tumbled by 43.21% to $92000.0 in 2018, then soared by 5334.78% to $5.0 million in 2019, then tumbled by 3100.0% to -$150.0 million in 2020.
  • Business Quant data shows Short-Term Debt issuances for HAE at -$150.0 million in Q4 2020, -$60.0 million in Q3 2020, and $150.0 million in Q2 2020.